J. Kodama et al., Thrombospondin-1 and-2 messenger RNA expression in invasive cervical cancer: Correlation with angiogenesis and prognosis, CLIN CANC R, 7(9), 2001, pp. 2826-2831
Purpose: TSP association with clinicopathological features, including micro
vessel count, regarding prognostic significance was examined in patients pr
esenting with invasive cervical cancer.
Experimental Design: Gene expression of TSP-1 and TSP-2 was assessed by rev
erse transcription-PCR in 10 normal cervix and 78 invasive cervical cancer
samples.
Results: TSP-1 and TSP-2 mRNA expression was detected in seven (70.0%) of t
he normal cervical specimens. TSP-2 mRNA expression in normal cervix was si
gnificantly higher than that in cases involving cervical cancer (P = 0.032)
. TSP-1 mRNA expression was significantly lower in tumors characterized by
advanced stage (P = 0.047). Fifty-three patients displaying stage Ib-IIb ce
rvical cancer underwent radical hysterectomy and pelvic lymphadenectomy. Ex
pression of TSP-1 and TSP-2 mRNA was significantly lower in tumors exhibiti
ng parametrial invasion (P = 0.016 and P = 0.049, respectively). Microvesse
l counts were significantly higher when decreased TSP-1 expression was evid
ent (P = 0.029). The microvessel count in patients lacking TSP-2 mRNA expre
ssion was higher than that observed in patients displaying TSP-2 mRNA expre
ssion, although it was not statistically significant (P = 0.062). Subjects
demonstrating TSP-1 mRNA expression exhibited significantly better prognosi
s than those lacking TSP-1 mRNA expression (P = 0.0038). Furthermore, TSP-1
mRNA expression was an independent prognostic factor in the multivariate a
nalysis.
Conclusions: These findings provide evidence that TSP-1 expression is of va
lue as a prognostic factor in cervical cancer. The inverse correlation betw
een TSP expression and microvessel count also indicates that decreased TSP
expression may be associated with an angiogenic phenotype in this class of
neoplasm.